The efficacy of local glucocorticosteroid therapy in nonarteritic anterior ischemic optic neuropathy
- Authors: Antonov V.A.1, Tultseva S.N.1, Astakhov S.Y.1, Grigoryeva N.N.2
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- St. Petersburg Territorial Diabetological Center
- Issue: Vol 16, No 2 (2023)
- Pages: 49-61
- Section: Original researches
- URL: https://journals.rcsi.science/ov/article/view/253836
- DOI: https://doi.org/10.17816/OV409847
- ID: 253836
Cite item
Abstract
BACKGROUND: Non-arteritic anterior ischemic optic neuropathy is the second most common optic neuropathy after glaucoma. The effectiveness of the glucocorticosteroid therapy use for the non-arteritic anterior ischemic optic neuropathy treatment remains a subject of debate. Currently, the search for markers of the disease’s “therapeutic window” is under way.
AIM: The aim of this study is to evaluate the use of local glucocorticosteroid therapy as an emergency care for non-arteritic anterior ischemic optic neuropathy.
MATERIALS AND METHODS: 41 patients with non-arteritic anterior ischemic optic neuropathy were enrolled in the study. To evaluate optic nerve head and macula morphometric characteristics, optical coherence tomography was performed, additionally, diameters of arteries and veins were assessed at 4 vascular arcades. Patients were divided into 2 groups according to the presence of intraretinal fluid. The first (main) group consisted of 23 patients with intraretinal fluid, in the second (control) group 18 patients without intraretinal fluid were included. The first group was further divided into two subgroups according to the medical aid recourse periods — up to 5 days, and from 6 to 21 days (subgroup 1 — 9 patients, subgroup 2 — 14 patients).
RESULTS: Correlations between the dynamics of optic nerve head edema changes and the caliber of arteries (negative correlation) and that of veins (positive correlation) were revealed. Sub-tenon injection of long-acting glucocorticosteroid did not lead to morpho-functional improvement in first group patients. Local short-acting glucocorticosteroid therapy accomplished in the acute period of the disease made it possible to achieve an improvement in best corrected visual acuity during the first month in group 1 patients without any further worsening of it.
CONCLUSIONS: When providing emergency care to patients with non-arteritic anterior ischemic optic neuropathy during the first 5 days from the disease onset, the local use of glucocorticosteroid therapy is advisable.
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir A. Antonov
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: antonov@alborada.fi
ORCID iD: 0000-0002-5823-8367
postgraduate student
Russian Federation, Saint PetersburgSvetlana N. Tultseva
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: tultceva@yandex.ru
ORCID iD: 0000-0002-9423-6772
SPIN-code: 3911-0704
Scopus Author ID: 57194338755
Dr. Sci. (Med.), professor
Russian Federation, Saint PetersburgSergey Y. Astakhov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: astakhov73@mail.ru
ORCID iD: 0000-0003-0777-4861
SPIN-code: 7732-1150
Scopus Author ID: 56660518500
Dr. Sci. (Med.), professor
Russian Federation, Saint PetersburgNurguyana N. Grigoryeva
St. Petersburg Territorial Diabetological Center
Email: grinur@mail.ru
ORCID iD: 0000-0002-3877-2474
SPIN-code: 7299-4748
Scopus Author ID: 57219513060
MD, candidate of medical sciences, ophthalmologist
Russian Federation, Saint PetersburgReferences
- Hayreh SS. Ischemic Optic Neuropathies. Springer-Verlag Berlin Heidelberg, 2011. 456 p. doi: 10.1007/978-3-642-11852-4
- Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischemic optic neuropathy. Eye (Lond). 2015;29(1):65–79. doi: 10.1038/eye.2014.144
- Berry S, Lin WV, Sadaka A, Lee AG. Nonarteritic anterior ischemic optic neuropathy: cause, effect and management. Eye and brain. 2017;2017(9):23–28. doi: 10.2147/EB.S125311
- Preechawat P, Bruce BB, Newman NJ, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol. 2007;144(6):953–960. doi: 10.1016/j.ajo.2007.07.031
- Levin LA, Danesh-Meyer HV. Hypothesis: a venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126(11):1582–1585. doi: 10.1001/archopht.126.11.1582
- Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114(11):1366–1374. doi: 10.1001/archopht.1996.01100140566007
- Callizo J, Feltgen N, Ammermann A, et al. Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy. PLoS One. 2017;12(8):181766. doi: 10.1371/journal.pone.0181766
- Sun M-H, Lee C-Y, Liao YJ, Sun C-C. Nonarteritic anterior ischaemic optic neuropathy and its association with obstructive sleep apnoea: a health insurance database study. Acta Ophthalmol. 2019;97(1): e64–e70. doi: 10.1111/aos.13832
- Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J ophthalmol. 1993;116(6):759–764. doi: 10.1016/S0002-9394(14)73478-6
- Purvin V, King R, Kawasaki A, Yee R. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch Ophthalmol. 2004;122(1):48–53. doi: 10.1001/archopht.122.1.48
- Hedges TR III, Vuong LR, Gonzalez-Garcia AO, et al. Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography. Arch Ophthalmol. 2008;126(6):812–815. doi: 10.1001/archopht.126.6.812
- Yu C, Ho JK, Liao YJ. Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy. Eye (Lond). 2014;28(12):1494–1501. doi: 10.1038/eye.2014.220
- Albrecht MC. Comparative anatomy of the optic nerve head and inner retina in non-primate animal models used for glaucoma research. Open Ophthalmol J. 2008;2:94–101. doi: 10.2174/1874364100802010094
- Storini M, Chan CKM, Cheng ACO, et al. The pathogenesis of nonarteritic anterior ischemic optic neuropathy. Asia-Pac J Ophthalmol. 2013;2(2):132–135. doi: 10.1097/APO.0b013e3182902e45
- Hayreh SS, Zimmerman MB. Optic disc edema in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(8):1107–1121. doi: 10.1007/s00417-006-0494-0
- Berkelaar M, Clarke DB, Wang YC, et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14(7):4368–4374. doi: 10.1523/JNEUROSCI.14-07-04368.1994
- Knox DL, Kerrison JB, Green WR. Histopatologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203–222.
- Mehrabian Z, Guo Y, Weinreich D, Bernstein SL. Oligodendrocyte death, neuroinflammation, and the effects of minocycline in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION). Molecular vision. 2017;23:963–976.
- Tesser RA, Niendorf ER, Levin LA. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003;110(10):2031–2035. doi: 10.1016/S0161-6420(03)00804-2
- Dickersin K, Everett D, Feldon F, et al. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273(8):625–632. doi: 10.1001/jama.273.8.625
- Soheilian M, Koochek A, Yazdani S, Peyman G. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina. 2003;23(5):692–697. doi: 10.1097/00006982-200310000-00015
- Modarres M, Sanjari MS, Falavarjani KG. Vitrectomy and release of presumed epipapillary vitreous traction of nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2007;114(2):340–344. doi: 10.1016/j.ophtha.2006.07.063
- Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuro-ophthalmol. 2007;27(3):238–240. doi: 10.1097/WNO.0b013e31814b273d
- Saxena R, Singh D, Sharma M, et al. Steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy: A randomized controlled trial. Ophthalmology. 2018;125(10):1623–1627. doi: 10.1016/j.ophtha.2018.03.032
- Pakravan M, Esfandiari H, Hassanpour K, et al. The effect of combined systemic erythropoietin and steroid on non-arteritic anterior ischemic optic neuropathy: a prospective study. Curr Eye Res. 2017;42(7):1079–1084. doi: 10.1080/02713683.2016.1270328
- Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuro-ophthalmol. 2007;27(3):164–168. doi: 10.1097/WNO.0b013e31814a5a9a
- Nuzzi R, Monteu F. Use of intravitreal dexamethasone in a case of anterior ischemic optic neuropathy. Case rep ophthalmol. 2017;8(2):452–458. doi: 10.1159/000479785
- Alten F, Clemens CR, Heiduschka P, Eter N. Intravitreal dexamethasone implant (Ozurdex) for the treatment of nonarteritic anterior ischemic optic neuropathy. Doc Ophthalmol. 2014;129(3):203–207. doi: 10.1007/s10633-014-9461-y
- Chen J, Zhu J, Chen L, et al. Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019;98(46): e17861. doi: 10.1097/MD.0000000000017861
- Lantos K, Dömötör ZR, Farkas N, et al. Efficacy of treatments in nonarteritic ischemic optic neuropathy: A systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(5):2718. doi: 10.3390/ijerph19052718
- Fesharaki H, Kianersi F, Shoyoukhi S. Therapeutic effect of posterior sub-Tenon methylprednisolone in AION: a randomized clinical trial. Iran J of Ophthalmol. 2011;23:50–56.